Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Morgan E Lorkowski"'
Autor:
Gil Covarrubias, Yahan Zhang, Morgan E Lorkowski, Efstathios Karathanasis, Prabhani U. Atukorale, Taylor J. Moon, Wyatt M. Becicka, Peter Bielecki
Publikováno v:
Nanoscale Advances
The efficacy of immunotherapies is often limited by the immunosuppressive tumor microenvironment, which is populated with dysfunctional innate immune cells. To reprogram the tumor-resident innate immune cells, we developed immunostimulatory silica me
Autor:
Prabhani U. Atukorale, Morgan E Lorkowski, Peter Bielecki, Efstathios Karathanasis, A.R. Santulli, Georgia Loutrianakis, Yahan Zhang, Kathleen Tong, Taylor Moon, Wyatt M. Becicka, Gil Covarrubias
Publikováno v:
J Control Release
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant disease, where even surgical resection and aggressive chemotherapy produce dismal outcomes. Immunotherapy is a promising alternative to conventional treatments, possessing the ability to e
Autor:
Gil Covarrubias, Taylor J. Moon, Shruthi Ravichandran, Efstathios Karathanasis, Prabhani U. Atukorale, Peter Bielecki, Michelle L. Wiese, Morgan E Lorkowski, Yahan Zhang, Wyatt M. Becicka
Publikováno v:
Nanoscale Horiz
The high mortality associated with glioblastoma multiforme (GBM) is attributed to its invasive nature, hypoxic core, resistant cell subpopulations and a highly immunosuppressive tumor microenvironment (TME). To support adaptive immune function and es
Autor:
Taylor J. Moon, Gil Covarrubias, Abdelrahman Rahmy, Anthony Cha, Anna Cristina S. Samia, Efstathios Karathanasis, Georgia Loutrianakis, Sameera Wickramasinghe, Morgan E Lorkowski, Haley M. Sims, Eric C. Abenojar
Publikováno v:
Nanoscale Advances
Iron oxide nanoparticles (IONPs) have often been investigated for tumor hyperthermia. IONPs act as heating foci in the presence of an alternating magnetic field (AMF). It has been shown that hyperthermia can significantly alter the tumor immune micro
Autor:
Mayura P Umapathy, Gil Covarrubias, Morgan E Lorkowski, Taylor J. Moon, Prabhani U. Atukorale, Georgia Loutrianakis, Haley M. Sims, Michelle L. Wiese, Efstathios Karathanasis, Peter Bielecki
Publikováno v:
J Mater Chem B
To alter the immunosuppressive tumor microenvironment (TME), we developed an immunostimulatory nanoparticle (NP) to reprogram a tumor’s dysfunctional and inhibitory antigen-presenting cells (APCs) into properly activated APCs that stimulate tumor-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef0b7261985c46e73d2c9810600885e7
https://europepmc.org/articles/PMC8732314/
https://europepmc.org/articles/PMC8732314/
Autor:
Kathleen Tong, Taylor Moon, Pubudu M. Peiris, Aaron Yun, S. Raghunathan, Youngjun Park, Vindya S. Perera, Gil Covarrubias, Morgan E Lorkowski, Mark A. Griswold, Oguz Turan, Deobrat Dixit, Jeremy N. Rich, Georgia Loutrianakis, Efstathios Karathanasis, Shane Cooley, Peter Bielecki, Ketan B. Ghaghada
Publikováno v:
Adv Ther (Weinh)
Glioblastomas (GBMs) remain highly lethal. This partially stems from the presence of brain tumor initiating cells (BTICs), a highly plastic cellular subpopulation that is resistant to current therapies. In addition to resistance, the blood-brain barr
Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy
Publikováno v:
Adv Healthc Mater
Recent advancements in unravelling elements of cancer biology involved in disease progression and treatment resistance have highlighted the need for a holistic approach to effectively tackle cancer. Stimuli-responsive nanotheranostics based on iron o
Autor:
Oguz Turan, Felicia He, B. Gnanasambandam, S. Raghunathan, C. Wu, Pubudu M. Peiris, Gil Covarrubias, Morgan E Lorkowski, William P Schiemann, Efstathios Karathanasis
Publikováno v:
Nanoscale. 10:6861-6871
Metastasis displays a highly heterogeneous cellular population with cancer cells continuously evolving. As a result, a single-ligand nanoparticle cannot account for the continuously changing expression of targetable biomarkers over time and space. To
Autor:
Sonya E.L. Craig, Abdelrahman Rahmy, Debashish Roy, Efstathios Karathanasis, Mette L. Johansen, Anthony Cha, Morgan E Lorkowski, Bryan Scott, Madhusudhana Gargesha, Bernadette O. Erokwu, Christopher A Flask, Jason Vincent, Susann M. Brady-Kalnay, Christina J MacAskill, Gil Covarrubias
Publikováno v:
Nanomedicine
Poor prognosis for glioblastoma (GBM) is a consequence of the aggressive and infiltrative nature of gliomas where individual cells migrate away from the main tumor to distant sites, making complete surgical resection and treatment difficult. In this
Autor:
Gil Covarrubias, Ramamurthy Gopalakrishnan, S. Raghunathan, Pubudu M. Peiris, Abdelrahman Rahmy, Kathleen Tong, Mark A. Griswold, Morgan E Lorkowski, T Ouyang, A Yun, Efstathios Karathanasis, Vindya S. Perera, Peter Bielecki, Ketan B. Ghaghada, Oguz Turan
Publikováno v:
Nanoscale
Glioblastomas are highly lethal cancers defined by resistance to conventional therapies and rapid recurrence. While new brain tumor cell-specific drugs are continuously becoming available, efficient drug delivery to brain tumors remains a limiting fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a37b73b948b75fa950e969742ddf55f
https://europepmc.org/articles/PMC7776621/
https://europepmc.org/articles/PMC7776621/